Clinical Trial Update: Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease

View source ↗

Summary

A clinical trial comparing tacrolimus versus methotrexate as rescue therapy for refractory inflammatory bowel disease; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China | Conditions: Inflammatory Bowel Diseases | Status: UNKNOWN